- © Copyright of Vietnamnet Global.
- Tel: 024 3772 7988 Fax: (024) 37722734
- Email: [email protected]
Update news ovarian cancer drug
The U.S. Food and Drug Administration on Thursday expanded the use of Lynparza, sold by AstraZeneca Plc and Merck & Co Inc, to include ongoing treatment of patients with recurrent ovarian cancer
Tesaro Inc said its experimental ovarian cancer drug niraparib met the main goal of prolonging survival in patients, without the disease worsening, in a late-stage trial, sending its shares to a record high.